24.06.2024 08:03:25 - dpa-AFX: *GSK : EMA REVIEWS JEMPERLI PLUS CHEMOTHERAPY FOR EXPANDED ENDOMETRIAL CANCER TREATMENT

Copyright(c) 2024 RTTNews.com. All Rights Reserved

Copyright RTT News/dpa-AFX
Name WKN Börse Kurs Datum/Zeit Diff. Diff. % Geld Brief Erster Schluss
GSK PLC LS-,3125 A3DMB5 Xetra 17,860 04.07.24 09:12:30 +0,105 +0,59% 17,895 17,940 17,860 17,755

© 2000-2024 DZ BANK AG. Bitte beachten Sie die Nutzungsbedingungen | Impressum
2024 Infront Financial Technology GmbH